C34H39N3O8 Cytidine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methox yethyl)-5-methyl- (9CI, ACI)

Canonical SMILES O=C1N=C(N)C(=CN1C2OC(COC(C=3C=CC=CC3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5)C(O)C2OCCOC)C
Isomeric SMILES C(OC[C@H]1O[C@H]([C@H](OCCOC)[C@@H]1O)N2C(=O)N=C(N)C(C)=C2)(C3=CC=C(OC)C=C3)(C4=CC=C(OC)C5=CC4)C
InChI
InChI=1S/C34H39N3O8/c1-22-20-37(33(39)36-31(22)35)32-30(43-19 -18-40-2)29(38)28(45-32)21-44-34(23-8-6-5-7-9-23,24-10-14-26(4) 1-3)15-11-24)25-12-16-27(42-4)17-13-25/h5-17,20,28-30,32,38H,18-19,21H2,1-4H3,(H2,35,36,39)/t28-,12
InChI Ki
LYKTVJJXZQTNPK-PBAMLIMUSA-N
24 Na inoa e ae no keia mea
5′-O-[Bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-5-methylcytidine (ACI); 11: PN: US20030170636 PAGE: 17 i koi iā RNA; 12: PN: US20030211606 PAGE: 18 i koi iā R NA; 12: PN: US20030212017 PAGE: 19 i koi iā R NA; 14: PN: US20040005569 PAG E: 21 koi ʻia ʻo R NA; 15: PN: US20040005565 PAGE: 17- 22 i koi ʻia ʻo RNA; 15: PN: US20040005570 PAGE: 19 i koi iā R NA; 15: PN: U S20040006030 PAGE: 22 koi ʻia ʻo R NA; 15: PN: US20040014048 PAGE: 19 i koi ʻia ʻo R NA; 16: PN: US20030171313 PAGE: 9 i koi ʻia ʻo RNA; 16: PN: US20030198965 PAGE: 19 i koi iā R NA; 16: PN: US20040014047 PAGE: 19 i koi ʻia ʻo R NA; 16: PN: US20040014049 PAGE:

19 i koi iā RNA; 17: PN: US20040014051 PAGE: 21 i koi iā R NA; 17: PN: US20040014699 PAGE: 19 i koi ʻia ʻo R NA; 17: PN: W
O03106645 PAGE: 69 koi R NA; 18: PN: US20040006029 PAGE: 22 i koi ʻia ʻo R NA; 2′-O-Methoxyethyl-5′-O-dimethoxytrityl-5- methylcytidine; 58: PN: US20030166592 PAGE: 15 i koi ʻia ʻo R NA; 5: PN: WO2005006958 PAGE: 61 koi ʻia ʻo R NA; 7: PN: WO20050 07825 PAGE: 61 koi ʻia ʻo R NA; 82: PN: US20040171566 PAGE: 18 i koi ʻia ʻo R NA; 89: PN: US20040005707 PAGE: 19 i koi ʻia ʻo R NA; 9: PN: WO03084478 PAGE: 56 koi ʻia ʻo R NA